IRhythm Net Invested Capital from 2010 to 2024
| IRTC Stock | USD 89.02 6.57 7.97% |
Net Invested Capital | First Reported 2010-12-31 | Previous Quarter 245 M | Current Value 246.5 M | Quarterly Volatility 89.9 M |
Check IRhythm Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IRhythm Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 23.3 M, Interest Expense of 2.6 M or Selling General Administrative of 404.9 M, as well as many indicators such as Price To Sales Ratio of 8.3, Dividend Yield of 0.0 or PTB Ratio of 8.61. IRhythm financial statements analysis is a perfect complement when working with IRhythm Technologies Valuation or Volatility modules.
IRhythm | Net Invested Capital |
Latest IRhythm Technologies' Net Invested Capital Growth Pattern
Below is the plot of the Net Invested Capital of iRhythm Technologies over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. IRhythm Technologies' Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IRhythm Technologies' overall financial position and show how it may be relating to other accounts over time.
| Net Invested Capital | 10 Years Trend |
|
Net Invested Capital |
| Timeline |
IRhythm Net Invested Capital Regression Statistics
| Arithmetic Mean | 173,978,008 | |
| Geometric Mean | 155,958,048 | |
| Coefficient Of Variation | 51.69 | |
| Mean Deviation | 76,249,210 | |
| Median | 113,531,000 | |
| Standard Deviation | 89,932,621 | |
| Sample Variance | 8087.9T | |
| Range | 285.3M | |
| R-Value | 0.74 | |
| Mean Square Error | 3983.5T | |
| R-Squared | 0.54 | |
| Significance | 0 | |
| Slope | 14,813,649 | |
| Total Sum of Squares | 113230.3T |
IRhythm Net Invested Capital History
About IRhythm Technologies Financial Statements
IRhythm Technologies stakeholders use historical fundamental indicators, such as IRhythm Technologies' Net Invested Capital, to determine how well the company is positioned to perform in the future. Although IRhythm Technologies investors may analyze each financial statement separately, they are all interrelated. For example, changes in IRhythm Technologies' assets and liabilities are reflected in the revenues and expenses on IRhythm Technologies' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in iRhythm Technologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Invested Capital | 245 M | 246.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iRhythm Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IRhythm Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Irhythm Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Irhythm Technologies Stock:Check out the analysis of IRhythm Technologies Correlation against competitors. For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IRhythm Technologies. If investors know IRhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IRhythm Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.85) | Revenue Per Share 18.045 | Quarterly Revenue Growth 0.184 | Return On Assets (0.09) | Return On Equity (1.03) |
The market value of iRhythm Technologies is measured differently than its book value, which is the value of IRhythm that is recorded on the company's balance sheet. Investors also form their own opinion of IRhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is IRhythm Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IRhythm Technologies' market value can be influenced by many factors that don't directly affect IRhythm Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IRhythm Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if IRhythm Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IRhythm Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.